Skip to main content
Clinical Trials/NCT03129529
NCT03129529
Completed
Not Applicable

Comparing the Effect of Focused and Radial Extracorporeal Shock Waves on Post-stroke Hypertonia

Mackay Memorial Hospital1 site in 1 country32 target enrollmentJanuary 1, 2016
ConditionsSpasticity

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Spasticity
Sponsor
Mackay Memorial Hospital
Enrollment
32
Locations
1
Primary Endpoint
Change from baseline of spasticity on 1st, 4th, 8th weeks after treatment.
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The main purpose of this study is to compare treatment efficacy of focused and radial extracorporeal shock waves on spasticity in chronic stroke patient

Detailed Description

This study is a prospective and double-blinded randomized control trial. Thirty-two stroke patients with spastic equinus were randomly assigned to receive three sessions of either focused shockwave therapy or radial shockwave therapy at 1-week intervals. The intensities that were used during FSWT (0.1 mJ/mm2) and RSWT (2 bar) were comparable. Patients were evaluated at baseline and at 1, 4, 8 weeks after the final shockwave treatment. The primary outcome measure was modified Ashworth scale (MAS) score. Secondary outcome measures were Tardieu scale, ankle passive range of motion, plantar contact area during gait, and gait speed. A linear mixed model with repeated measures was used to compare each outcome measure between the two groups.

Registry
clinicaltrials.gov
Start Date
January 1, 2016
End Date
January 1, 2017
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Gwo-Chi Hu,PHD

PHD

Mackay Memorial Hospital

Eligibility Criteria

Inclusion Criteria

  • aged greater than 18 years old;
  • at least 6 months since onset of last stroke;
  • triceps surae muscle tone graded at least 1+ on the Modified Ashworth Scale (MAS) score;
  • ability to walk alone with/without orthosis.

Exclusion Criteria

  • Exclusion criteria included fixed ankle joint contracture, previous treatment of the affected leg with neurolytic or surgical procedures, concomitant progressive central nervous system diseases, and skin breakdown, vascular disease in the affected leg

Outcomes

Primary Outcomes

Change from baseline of spasticity on 1st, 4th, 8th weeks after treatment.

Time Frame: 1, 4, 8 week

Using the modyfied Ashworth Scale to measure the spasticity before treatment and multiple time frame after treatment.

Secondary Outcomes

  • Change from baseline of range of motion on 1st, 4th, 8th weeks after treatment.(1, 4, 8 week)
  • Change from baseline of modified Tardieu scale on 1st, 4th, 8th weeks after treatment.(1, 4, 8 week)
  • Change from baseline of foot contact area on 1st, 4th, 8th weeks after treatment.(1, 4, 8 week)
  • Change from baseline of gait speed on 8th weeks after treatment.(8 week)

Study Sites (1)

Loading locations...

Similar Trials